Another Tylenol recall has been announced by Johnson and Johnson subsidiary McNeil Consumer Healthcare. The Tylenol recall is the 5th recall in a year for the drug maker, which is under investigation by Congress for its quality control practices. A musty scent coming from the bottles triggered the latest recall of the popular over-the-counter medicine.
The recall signifies returning any 8-hour Tylenol
The latest Tylenol recall was announced Monday. 128,000 bottles of 50-count Tylenol 8-Hour Caplets were taken back voluntarily by Johnson and Johnson’s McNeil Consumer Healthcare division. The Tylenol 8-hour merchandise had a “musty or moldy odor” that had been complained about in the United States and Puerto Rico which called for McNeil to initiate the recall, accounts the NY Times. The Tylenol recalled was made at the company’s troubled Fort Washington, Pennsylvania, plant before the facility had been closed in March. The cause of the recall is the same excuse for why there had been a Tylenol recall in January, June and July with goods produced in Puerto Rico at the McNeil facility. They said a chemical used to treat wooden transport pallets that leached to the Tylenol probably caused there to be a moldy smell.
Tylenol recalls over and over
A congressional inquiry has been going into Johnson and Johnson. This is because there have been a number of recalls just this year. Due to nausea, stomach pain, vomiting and diarrhea, five lots of 100-count Tylenol Arthritis Pain were recalled, accounts Cable News Network, just last November. All lots of the product were recalled later in December. Tylenol and Motrin were both part of yet another recall that expanded this that occurred in January. Odor complaints and nausea were what brought on this recall to happen. In May, 50 children’s medicines were recalled because of quality control and safety concerns.
Making sure you control facilities much better
Johnson and Johnson closed the McNeil plant in April. According to Reuters, Johnson and Johnson is revamping all of the level of quality control plans within the plant. This is so that the violations found by the United States FDA could be fixed. Based on the FDA, the plant had contaminated drug ingredients. There was also dust and grime everywhere. Johnson and Johnson’s bottom line got about $650 million a year just from the drugs manufactured at the Fort Washington plant. Based on Bloomberg, the recalls and facility closings will cost the business a lot. In fact, $600 billion will be lost this year because of it.
Information from
New York Times
prescriptions.blogs.nytimes.com/2010/10/18/more-trouble-with-tylenol/?partner=rss and emc=rss
CNN
cnn.com/2010/HEALTH/10/19/tylenol.recall/index.html?npt=NP1
Reuters
reuters.com/article/idUSTRE69I2W320101019
No comments:
Post a Comment